ARTICLE | Company News
Boehringer Ingelheim Pharmaceuticals Inc. infectious diseases/aids news
February 5, 1996 8:00 AM UTC
The company said it will establish an expanded access program for Viramune (Nevirapine), a reverse transcriptase inhibitor for AIDS patients, which it expects will begin in March following FDA approv...